Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Dec 27;48(1):4.
doi: 10.1007/s10143-024-03150-0.

Factors affecting hormonal outcomes in patients undergoing surgery for non-functioning pituitary neuroendocrine tumors: a prospective observational study

Harsimran Singh  1 , Achal Sharma  1 , Madhur Choudhary  1 , Gaurav Jain  2 , Vinod Sharma  1
Affiliations
Observational Study

Factors affecting hormonal outcomes in patients undergoing surgery for non-functioning pituitary neuroendocrine tumors: a prospective observational study

Harsimran Singh et al. Neurosurg Rev. .

Abstract

Surgical resection of non-functioning pituitary neuroendocrine tumors (NF-PitNET) is associated with new onset hormonal axis (HA) dysfunction, and factors predicting HA dysfunction are controversial, especially in large and giant NF-PitNET. Thus, we evaluated the postoperative hormonal function and assessed factors affecting HA dysfunction in patients with NF-PitNET. This prospective observational study involved 50 patients who underwent endoscopic surgical resection of NF-PitNET in the Department of Neurosurgery (April 2023-March 2024). The preoperative tumor diameter and volume were calculated radiologically. Hormonal evaluation was performed preoperatively, and again postoperatively at 7-days and 90-days. At 90-days, 36% patients recovered HA function, 34% remained unchanged, while 30% worsened. Serum cortisol (p < 0.0001), adrenocorticotropic hormone (p = 0.012), growth hormone (p = 0.013), and luteinizing hormone (p = 0.020) levels increased significantly; serum prolactin (p = 0.016) decreased significantly; while serum thyroid-stimulating hormone, follicle-stimulating hormone, and testosterone levels remained unchanged (all p > 0.05). Overall, there was no significant change in grade of HA dysfunction (p > 0.05). Male sex (OR:5.630, 95%CI:1.648-19.232; p = 0.006), tumor volume (OR:3.511, 95%CI:1.308-9.423; p = 0.013) and tumor diameter (OR:9.489, 95%CI:2.916-30.878; p < 0.0001) were significantly associated with postoperative HA dysfunction. Tumor volume and diameter (cut-off: 8.87 cm3 and 2.95 cm, respectively) predicted postoperative HA dysfunction with a sensitivity of 96.0% and 92.0%, and a specificity of 88.0% and 76.0%, respectively. New-onset diabetes insipidus (30%) was the predominant complication. Tumor diameter and volume are significant predictors of postoperative HA dysfunction. More than one third of patients improved their HA function, while it worsened in less than a third of patients.

Keywords: Giant pituitary neuroendocrine tumors; Hypopituitarism; Non-functioning pituitary neuroendocrine tumors; Pituitary surgery; Tumor volume.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of SMS Medical College and Attached Hospitals, Jaipur (Date April 4, 2023 No. 161/MC/EC/2023). Consent to participate: Informed consent was obtained from all the patients included in the study. Consent to publish: Consent for publication was obtained from the patients. Informed consent: Informed consent was obtained from the patients. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Esposito D, Olsson DS, Ragnarsson O, Buchfelder M, Skoglund T, Johannsson G (2019) Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 22:422–434. https://doi.org/10.1007/s11102-019-00960-0 - DOI - PubMed - PMC
    1. AlMalki MH, Ahmad MM, Brema I, AlDahmani KM, Pervez N, Al-Dandan S et al (2020) Contemporary Management of clinically non-functioning pituitary adenomas: a clinical review. Clin Med Insights Endocrinol Diabetes 13:1179551420932921. https://doi.org/10.1177/1179551420932921 - DOI - PubMed - PMC
    1. Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21:111–118. https://doi.org/10.1007/s11102-018-0869-3 - DOI - PubMed
    1. Drummond JB, Ribeiro-Oliveira A, Soares BS (2000) Non-Functioning Pituitary Adenomas. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, editors. PubMed. South Dartmouth (MA): MDText.com, Inc.; 2000 [updated Oct 12 2022; accessed Jun 22 2024]. https://www.ncbi.nlm.nih.gov/books/NBK534880/
    1. Varlamov EV, McCartney S, Fleseriu M (2019) Functioning pituitary adenomas: current treatment options and emerging medical therapies. Eur Endocrinol 15:30–40. https://doi.org/10.17925/EE.2019.15.1.30 - DOI - PubMed - PMC

Publication types

Substances

LinkOut - more resources